Replies to post #364705 on Amarin Corp Plc (AMRN)

[xblkbk]

I don’t know if she uses the same data provider as RAF, but this was the weekly commentary that the JP Morgan analyst put out yesterday:

Vascepa EUTRx for the week was 9,339,906 which translates to roughly 77,833 Vascepa bottles sold, down from 79,260 bottles last week. Our EUTRx to bottle conversions are based on the standard package size of these products, comprising 120 capsules per bottle.

Based on EUTRx, branded Vascepa market share within the omega-3 fatty acid market averaged 53.1% in 1Q, 52.3% in 2Q and 50.3% in 3Q. So far in 4Q, this share has averaged 48.1%.

Based on EUTRx, in the latest week generic Vascepa had 23.3% share of overall icosapent ethyl volume (Vascepa+generic Vascepa) and 14.5% share YTD.